Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cornea ; 12(3): 222-7, 1993 May.
Artigo em Inglês | MEDLINE | ID: mdl-8500335

RESUMO

Gentamicin is the only antibiotic currently added to commercially available corneal storage media. To reduce the potential for bacterial dissemination from donor corneal tissue to the recipient eye, we evaluated the addition of vancomycin to corneal storage media. When added to Dexsol at a concentration of 200 micrograms/ml, vancomycin levels were maintained, showing a 7% decrease in vancomycin concentration per month, measured < or = 90 days after its addition. Human corneas were stored in gentamicin-free Dexsol (Chiron Ophthalmics, Inc., Irvine, CA, U.S.A.) containing 150 micrograms/ml vancomycin. Corneal tissue levels of vancomycin determined by agar diffusion bioassay were 201, 226, 292 micrograms/ml at 1, 3, and 7 days of storage respectively, suggesting that corneal tissue concentrates vancomycin with time. No differences in endothelial cell count or cell death were seen in corneas stored in Dexsol (containing gentamicin) or Dexsol plus vancomycin when followed for < or = 14 days. Vancomycin added to corneal storage media should reduce the potential for endophthalmitis due to gentamicin-resistant organisms.


Assuntos
Córnea/metabolismo , Meios de Cultura Livres de Soro , Vancomicina/farmacocinética , Contagem de Células/efeitos dos fármacos , Sobrevivência Celular , Sulfatos de Condroitina , Córnea/citologia , Estabilidade de Medicamentos , Endotélio Corneano/citologia , Endotélio Corneano/efeitos dos fármacos , Gentamicinas/efeitos adversos , Gentamicinas/farmacocinética , HEPES , Humanos , Preservação de Órgãos , Compostos Orgânicos , Vancomicina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...